BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21853527)

  • 21. Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
    Hiraki S; Ormond KE; Kim K; Ross LF
    Am J Med Genet A; 2006 Nov; 140(21):2312-9. PubMed ID: 17036312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation analysis in newborn screening for fragile X syndrome--reply.
    Tassone F
    JAMA Neurol; 2014 Jun; 71(6):800-1. PubMed ID: 24911127
    [No Abstract]   [Full Text] [Related]  

  • 23. Pediatricians' attitudes toward expanding newborn screening.
    Acharya K; Ackerman PD; Ross LF
    Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn, carrier, and early childhood screening recommendations for fragile X.
    Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
    Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatricians' knowledge of and attitudes toward fragile X syndrome screening.
    Kemper AR; Bailey DB
    Acad Pediatr; 2009; 9(2):114-7. PubMed ID: 19329102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes toward population screening among people living with fragile X syndrome in the UK: 'I wouldn't wish him away, I'd just wish his fragile X syndrome away'.
    Boardman FK
    J Genet Couns; 2021 Feb; 30(1):85-97. PubMed ID: 33184995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ask the expert. Genetic testing for fragile X.
    Prows CA; Lovell AM
    J Soc Pediatr Nurs; 1998; 3(4):161-6. PubMed ID: 9884950
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessing the Fragile X Syndrome Newborn Screening Landscape.
    Riley C; Wheeler A
    Pediatrics; 2017 Jun; 139(Suppl 3):S207-S215. PubMed ID: 28814541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newborn screening policy in the United Kingdom & the United States: two different communities of practice.
    Patch C
    MCN Am J Matern Child Nurs; 2006; 31(3):164-8. PubMed ID: 16679957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing fragile X syndrome.
    Moore DY
    Lancet; 1993 Dec 18-25; 342(8886-8887):1563-4. PubMed ID: 7902945
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group.
    de Vries BB; van den Ouweland AM; Mohkamsing S; Duivenvoorden HJ; Mol E; Gelsema K; van Rijn M; Halley DJ; Sandkuijl LA; Oostra BA; Tibben A; Niermeijer MF
    Am J Hum Genet; 1997 Sep; 61(3):660-7. PubMed ID: 9326332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn screening in North Carolina: the evolution of policy and practice.
    Kirkman HN
    N C Med J; 2008; 69(2):92-7. PubMed ID: 18605155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragile X syndrome testing in the North West.
    Smith K; Chandler K; Hindley D; Ramsden SC
    Arch Dis Child; 2013 Mar; 98(3):239. PubMed ID: 23334255
    [No Abstract]   [Full Text] [Related]  

  • 34. [A large-scale diagnostic program for the fragile X syndrome among the mentally handicapped. I. An epidemiologic survey].
    de Vries LB; van den Ouweland AM; Mohkamsing S; Sandkuijl LA; Oostra BA; Niermeijer MF
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1666-71. PubMed ID: 9890806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragile X syndrome carrier screening in the prenatal genetic counseling setting.
    Cronister A; DiMaio M; Mahoney MJ; Donnenfeld AE; Hallam S
    Genet Med; 2005 Apr; 7(4):246-50. PubMed ID: 15834242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragile X and company: finding the right diagnosis.
    Subramony SH; Friedrich CA; Jankowiak J
    Neurology; 2005 Jul; 65(2):E3-4. PubMed ID: 16043779
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular genetic screening in cytogenetically normal mentally retarded males with manifestations of fragile X syndrome.
    Butler MG; Pratesi R; Vnencak-Jones CL
    Am J Med Genet; 1994 Jul; 51(4):315-6. PubMed ID: 7942993
    [No Abstract]   [Full Text] [Related]  

  • 38. The Legal Dimensions of Genomic Sequencing in Newborn Screening.
    Zacharias RL; Smith ME; King JS
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S39-S41. PubMed ID: 30133728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in prenatal screening and counselling for fragile X syndrome.
    Mak AS; Leung KY
    Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
    [No Abstract]   [Full Text] [Related]  

  • 40. Duty of care owed to parents of child with genetic disorder.
    Hosp Law Newsl; 2005 Jan; 22(3):1-5. PubMed ID: 15666554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.